Characteristics and Outcomes of US Veterans With Immunocompromised Conditions at High Risk of SARS-CoV-2 Infection With or Without Receipt of Oral Antiviral Agents
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciad504 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Chris A Gentry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chief of Pharmacy, Pharmacy Service, Oklahoma City Veterans Affairs Health Care System, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: COVID-19, Veterans, Hydroxylamines, Nitriles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objectives
Molnupiravir and nirmatrelvir-ritonavir were the first oral antiviral agents to demonstrate reduced hospitalization or death in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but patients with immunocompromised conditions were not well-represented. The objective of this study was to characterize and compare the clinical outcomes of US veterans with immunocompromised conditions prescribed oral antivirals with those who did not receive oral antivirals for mild-to-moderate SARS-CoV-2 active infection.
Methods
This was a retrospective, observational, nationwide propensity-matched analysis of US veterans with immunocompromised conditions who developed documented SARS-CoV-2 infection. The primary outcome was the composite of any hospitalization or death within 30 days of diagnosis. Secondary outcomes included 30-day comparative rates of (1) any hospitalization, (2) death, (3) intensive care requirement, and (4) subset analyses of outcomes by oral antiviral used and vaccination status.
Results
The composite primary outcome was significantly lower in patients receiving oral antiviral therapy compared with those who did not (23/390 [5.9%] vs 57/390 [14.6%]; odds ratio, 0.37; 95% confidence interval, .22–.61). This difference was driven largely by fewer deaths in the oral antiviral group (1/390 [0.3%] vs 19/390 [4.9%]; odds ratio, 0.05; 95% confidence interval, .007–.38). There was no significant difference in rate of intensive care requirement. The composite outcome was improved in vaccinated patients (completing the first series or first booster dose) who received oral antiviral agents compared with those who did not receive oral antiviral agents. Compared with those prescribed nirmatrelvir-ritonavir, patients given molnupiravir were older, had a higher incidence of cautions/contraindications, greater prevalence of tobacco use, and more cardiovascular complications.
Conclusions
Use of molnupiravir or nirmatrelvir-ritonavir was associated with lower incidences of hospitalization or death within 30 days of diagnosis in US veterans with immunocompromised conditions, regardless of vaccination status. These findings support the use of either oral antiviral in this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chief of Pharmacy, Pharmacy Service, Oklahoma City Veterans Affairs Health Care System, Oklahoma City, Oklahoma, USA.
- PGY2 Infectious Diseases Pharmacy Resident, Pharmacy Service, Oklahoma City Veterans Affairs Health Care System, Oklahoma City, Oklahoma, USA.
- Infectious Diseases Section Chief, Medical Service, Oklahoma City Veterans Affairs Health Care System, Oklahoma City, Oklahoma, USA.
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
- Chief of Medicine, Medical Service, Oklahoma City Veterans Affairs Health Care System, Oklahoma City, Oklahoma, USA.
- Infectious Diseases, Pharmacy Service, Oklahoma City Veterans Affairs Health Care System, Oklahoma City, Oklahoma, USA.
ORCID-Profile: Phoi N Nguyen
Zitieren
APA
Gentry, C. A., Nguyen, P. N., Thind, S. K., Kurdgelashvili, G., & Williams, R. J. (2024). Characteristics and Outcomes of US Veterans With Immunocompromised Conditions at High Risk of SARS-CoV-2 Infection With or Without Receipt of Oral Antiviral Agents. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad504
Vancouver
Gentry CA, Nguyen PN, Thind SK, Kurdgelashvili G, Williams RJ. Characteristics and Outcomes of US Veterans With Immunocompromised Conditions at High Risk of SARS-CoV-2 Infection With or Without Receipt of Oral Antiviral Agents. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad504
BibTeX
@article{Gentry2024,
author = {Gentry, Chris A and Nguyen, Phoi N and Thind, Sharanjeet K and Kurdgelashvili, George and Williams, Riley J},
title = {Characteristics and Outcomes of US Veterans With Immunocompromised Conditions at High Risk of SARS-CoV-2 Infection With or Without Receipt of Oral Antiviral Agents},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciad504}
}
EUVIMED